title: [Treatment of alcoholic liver diseases. Abstinence, nutritional support, drug therapy, liver transplantation].
abstract: The review summarizes clinically established treatment forms of alcoholic liver disease in four main chapters: abstinence, nutritional supportation, drug therapy and liver transplantation are discussed. Drug therapy is described according to the three types of alcoholic hepatopathies (fatty liver, hepatitis and cirrhosis). Early diagnosis and treatment depending on the severity and stage of alcoholic liver disease are of importance for the attempts to retard progression and improve prognosis.
authors.affiliation: I. Belgyógyászati Klinika, Pécsi Tudományegyetem, Altalános Orvostudományi Kar.
authors.forename: A
authors.initials: A
authors.lastname: Pár
mesh_terms: D000427:Alcohol Deterrents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D004338:Drug Combinations; D005235:Fatty Liver, Alcoholic / Q000628:therapy; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008099:Liver / Q000187:drug effects; D008104:Liver Cirrhosis, Alcoholic / Q000628:therapy; D008108:Liver Diseases, Alcoholic / Q000150:complications / Q000178:diet therapy / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D018529:Nutritional Support / Q000379:methods; D020011:Protective Agents / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D011761:Pyrrolidonecarboxylic Acid / Q000627:therapeutic use; D012838:Silymarin / Q000627:therapeutic use
chemical_list: D000427:Alcohol Deterrents; D000975:Antioxidants; D004338:Drug Combinations; D006728:Hormones; D009292:Narcotic Antagonists; D020011:Protective Agents; D012838:Silymarin; D009271:Naltrexone; C037845:metadoxine; D011736:Pyridoxine; D011761:Pyrrolidonecarboxylic Acid